石四药集团(02005)于国家集采接续采购中共45个品种的产品拟中标

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced that it plans to bid for 45 products in the upcoming national centralized procurement in China, which is expected to positively impact its business [1] Group 1: Product Categories - The 45 products cover various therapeutic areas including anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system [1]